The UK Spent £58 Billion on Research. Here Is What It Did Not Buy.

Faraz Rizvi · 14 May 2026 · Piece 1 of 4 · Markdown

Faraz Rizvi is a UK operator-practitioner writing about the work between a research breakthrough and a fundable company. He runs SpinUp Forge.

I keep reading about the R&D settlement as though the headline number is the story. I think the small print is the story.

The headline number is £58.5 billion, the DSIT R&D spending plan to 2029/30, announced with the kind of fanfare that a nine-figure commitment deserves. Set against that, reportedly around £40 million over five years ring-fenced specifically for spinout proof-of-concept support, a figure cited in the Autumn Budget 2024 narrative. That works out to roughly £8 million per year, distributed across the entire country. Every research university, every technology transfer office (TTO, the units inside universities responsible for commercialising research), every nascent spinout trying to get from a lab result to a term sheet. Eight million pounds, nationally, annually. I am not saying that as a criticism. I am saying it as a description, because it locates where the system actually draws its lines.

The shape of the flow is easier to read as a diagram than as a paragraph. The proportional reading below traces the £58.5 billion DSIT envelope through UKRI into the bucket-level allocations, then through the innovation-and-commercialisation pillar to the £8 million per year that reaches spinout proof-of-concept support nationally. The proportions, not the labels, are the point, the load-bearing visual is the funnel narrowing as the flow moves from research envelope to spinout-stage support.

UKRI 2026/27 funding flow from DSIT envelope to spinout proof-of-concept (£m)

Level 1, DSIT envelope

UKRI£9,200m

Other DSIT functions£49,300m

Level 2, UKRI buckets (of £9,200m)

Curiosity-driven research (research councils)£3,650m

Missions£1,920m

Cross-cutting research infrastructure£2,000m

Innovation & commercialisation (Innovate UK + Research England HEIF)£1,640m

Level 3, Inside innovation & commercialisation (of £1,640m)

Innovate UK generic competitions and Velocity£1,490m

Other commercialisation£142m

Spinout proof-of-concept support (nationally)£8m

The funding funnel is narrowing

£58.5 billion went to UK R&D; around £8 million per year reached spinout proof-of-concept support.

To understand why that number sits where it does, it helps to look at how UKRI, the umbrella body for UK public research and innovation funding, has structured its 2026/27 budget of £9.2 billion. The money flows into roughly four buckets. Curiosity-driven research receives £3.65 billion. This is the open-ended, investigator-led science that produces the discoveries spinouts are eventually built on. Missions, focused programmes around national priorities like net zero or health, receive £1.92 billion. The innovation and commercialisation pillar, which includes Innovate UK and its business-facing programmes, receives £1.64 billion. This is the bucket that InnovateUK insiders sometimes call "bucket 3" in private conversation, and it is where the spinout-support instruments live. Cross-cutting innovation infrastructure receives approximately £2 billion.

The direction of travel within this architecture is not subtle. According to Cambridge IIP's 2026 executive summary and confirmed by Research Professional News, curiosity-driven research is held at flat cash through to 2030, which means, in real terms accounting for inflation, a cut. The top of the funnel is being quietly narrowed at the same moment the bottom is being asked to produce more.

The official critique of this architecture has been stated plainly enough that I do not need to paraphrase it. Tim Harper wrote in his analysis of the UKRI 2025-26 budget: "Changing budget diagrams is easier than changing culture. Universities still largely reward being cited, not being manufactured. The safest academic career path is usually another paper and another grant, not a risky spin-out that might fail." That is the institutional logic problem sitting under the architecture problem. The National Audit Office, in HC 875 published May 2025, was more measured but reached adjacent territory, formally questioning whether the grant-based model is delivering on growth and productivity outcomes. Harper and the NAO are pointing at the same gap from different angles. The incentive structure inside universities was not designed to produce spinouts, and no budget reallocation changes that without also changing what universities measure, what they reward, and what they fund as a legitimate career outcome. The emerging shared TTO pilots, the Wessex consortium's CCF-RED model, for instance, or UAL's on-demand commercialisation approach, are capacity responses to this structural problem, not solutions to it. The cultural incentive structure that Harper names runs above the TTO layer. Both can be true: capacity workarounds can help individual spinouts while the underlying incentive architecture remains unchanged.

The policy is shifting

Innovate UK's Velocity restructuring marks the moment the state stops being a grants window and starts being an account-managed pathway, with operational maturity as the entry condition.

The clearest policy-shift signal of 2026 is Innovate UK's Velocity restructuring, announced in March and now entering implementation. Velocity replaces the generic-grant-competition model with an account-managed pipeline organised around six priority sectors, advanced manufacturing, clean energy, creative industries, defence, life sciences, and digital and technologies, and positions Innovate UK as a "trusted due diligence engine" for the deep-tech ecosystem. Grants and loans are calibrated to stage and risk rather than awarded through open calls. The move is structural: it changes what the state offers a spinout, from a chance at funding to a relationship with the institution that validates technical maturity before introducing it to capital. The condition for entering the pipeline is operational maturity already in place, board governance, financial controls, product roadmap, go-to-market clarity. The argument in the rest of this piece about the cost line of the funding system follows from this premise: the metrics the state now buys with the same pound are different from the metrics it bought in 2024 (UKRI announcement, March 2026; CIIP UK Innovation Report 2026).

The output data does not contradict either Harper or the NAO. Cambridge Industrial Innovation Policy's UK Innovation Report 2026 finds that "excellence in research and innovation doesn't automatically translate into industrial competitiveness", their language, not mine. The UK ranks fourth globally for scientific publications and spends 2.68% of GDP on R&D. What I notice, reading across the recent industrial strategy documents, is a science-innovation paradox sitting just under the surface of each one. The input metrics are strong, the output metrics are structurally weak. That is my framing, not Cambridge IIP's, but the data they and others have assembled makes it difficult to reach a different conclusion. Beauhurst's 2025 analysis of investment into UK spinouts found that spinouts raised £1.96 billion across 384 deals, a number that sounds significant until you note that 36.7% of those fundraisings were under £500,000, and only 57 UK spinouts have ever raised between €20–29.9 million, with 42 at €30–39.9 million. The Royal Academy of Engineering put it with characteristic dryness: the UK is the top European deep-tech hub and startup champion, but weak at late-stage investment. The geographic concentration compounds the structural problem. According to Success Knocks' 2026 analysis of UK VC trends, UK venture capital is heavily concentrated geographically: approximately 45% of all UK venture investment is in London, with a further 25% in the Cambridge/Oxford/Brighton corridor, meaning around 70% of the capital flows to a geography that represents a fraction of the UK's research base. (Deep-tech venture capital represents approximately 12% of all UK VC by contrast, a smaller but increasingly focused segment.)

One data point clarifies what this policy activity is responding to. The average university equity stake in spinouts fell to 16.1% in 2024, the lowest level in at least a decade and a 5.4 percentage-point drop in a single year, per the RAEng/Beauhurst Spotlight on Spinouts 2025. More than 50 universities have formally adopted the USIT or Tracey review guidelines. The terms question, which dominated the spinout debate for a decade, is converging toward resolution. What remains open is the throughput question: how quickly and cheaply a spinout can incorporate, licence IP, hire, and become investable once the terms are agreed. That is the gap the recent policy moves are attempting to address, and it is where the rest of this series situates its argument.

Against that backdrop, recent policy moves deserve a precise reading rather than either celebration or dismissal. The Innovate UK Venture Builder Pilot offers £150,000 per spinout, with expressions of interest open until 22 May 2026 and the programme scheduled to start in October 2026. The eligibility design is worth reading as a diagnostic statement. Applicants must have completed the ICURe Exploit gate (ICURe, Innovation to Commercialisation of University Research, is the national programme that funds academics to test commercial hypotheses). Prior external funding must not exceed £100,000. The stated purpose is to "close the gap between validated customer discovery and investment readiness." That is government naming a specific gap in programme terms and allocating capital against it. I find that meaningful. The stage-2 programme runs nine months, funding investability-building only, not technical milestones, not further research, which is government naming the execution gap in the programme design itself. ARIA's Activation Partners Cohort 2, with a £100 million envelope and a new AI-in-Science pillar funding lab-in-the-loop infrastructure and AI Scientists, had applications that closed on 21 May 2026. Another signal that the frontier of the funding system is moving toward translational infrastructure. Simultaneously, the Technology Transfer from Businesses and Educational Organisations exemption (TTBEO, the legal framework governing how IP can be transferred from universities to commercial entities) came into force on 30 April 2026 per SI 2026/369, with database rights now in scope of the exemption. Every TTO in the country is absorbing a legal-scaffolding change at the same moment the commercial expectations on them are rising. This is a system mid-transition, not a system that has arrived.

Operational proof and productivity needs to catch up

The argument is not that more money is needed; the cost line is now buying a different productivity result than it bought in 2024.

What I would not have said even nine months ago is that the cost line is now buying a different productivity envelope than it would have bought in 2024. A 2026-vintage operator working against codified agentic workflows is not bringing 2024-vintage output to the role, and Piece 2 of this series sets out the evidence for that change in some detail. If I were sitting in DSIT or Innovate UK with permission to move one number inside the Venture Builder Pilot tomorrow, I would ring-fence between 10% and 25% of the £150,000 unit for a named operator-cost line, explicit permission in the grant terms for spinouts to spend that money on a non-academic operator rather than further technical milestones. That change would not require new legislation or a new programme. It would require a decision that the gap between a validated research finding and a company ready for investment is partly a management and commercial execution problem, not only a science problem. Piece 3 returns to what that means in practice in the first 18 months of a spinout's life. The architecture already suggests policymakers know this. The unit economics have not caught up yet.

The funding system has changed its question. Most of the infrastructure around it is still answering the old one.

Note on assumptions and sourcing: The £40m spinout proof-of-concept figure is reported in the Autumn Budget 2024 narrative and used here as "reportedly around £40m." The UKRI budget split figures are drawn from the Cambridge IIP executive summary. The proportional Sankey diagram values are in £m and reflect those bucket-level figures; the £8m spinout PoC line represents the Autumn Budget 2024 ring-fenced figure as an indicative proportional reading rather than a precise audited line in the UKRI budget. Beauhurst deal counts and raise-size distributions are from their 2025 spinout investment report. The 16.1% average university equity stake figure is from RAEng/Beauhurst Spotlight on Spinouts 2025. Geographic VC concentration figures are from Success Knocks 2026; the breakdown is cited as approximately 45% (London) and approximately 25% (Cambridge/Oxford/Brighton corridor). Deep-tech venture capital represents approximately 12% of all UK VC. The IUK Velocity claim (six priority sectors, "trusted due diligence engine" framing, account-managed pipeline) is from the UKRI March 2026 announcement and should be cross-checked against any UKRI implementation updates before re-publication.

← Back to SpinUp Forge